Who are the primary customers in China? Are the major players selling to research labs, budding pharmaceutical companies?
From my personal knowledge, if you look at the Chinese market, the big market there is the diagnostic market, because the government really promotes disease prevention programs and early diagnosis. That is the biggest market. And they do have a lot of diagnostic biochips. [They have developed a] microarray chip for diabetes, and some kind of other diseases. So, that’s the biggest market segment. The next one would be research, and the last one would be pharmaceutical. Actually, pharmaceutical is a really, really small segment. As you may or may not know, a lot of pharmaceutical companies in China don’t do R&D at all. What they do is get the raw materials from overseas, make a product in China, and then sell the product in China. This is their business model. And who are the major players in the Chinese market today? There are a couple of big players. First of all we have to separate the Chinese companies and the foreign companies. So the foreign companies are Affymetrix, Agilent, ABI,
